Predictors for Long-Term Prognosis after Acute Coronary Syndrome
References
- 1. Sanchis-Gomar F, Perez-Quilis C, Leischik R, Lucia A. Epidemiology of coronary heart disease and acute coronary syndrome. Ann Transl Med. 2016;4(13):256.
- 2. Mahmood S, Levy D, Vasan R, Wangb T. The Framingham Heart Study and the Epidemiology of Cardiovascular Diseases: A HistoricalPerspective. Lancet. 2014;383(9921):999-1008.
- 3. Splansky GL, Corey D, Yang Q, et al. The third generation cohort of the National Heart, Lung, and Blood Institute’s Framingham Heart Study: design, recruitment, andinitial examination. Am J Epidemiol. 2007;165:1328-35.
- 4. Kannel W, Dawber T, Cohen M, McNamara P. Vascular disease of the Brain-Epidemiologic Aspects: the Farmingham Study. Am J Public Health Nations Health. 1965;55:1355-66
- 5. Wilson P, D’Agostino R, Levy D, Belanger A, Silbershatz H, Kannel W. Prediction of coronary heartdisease using risk factor categories. Circulation. 1998;97:1837-47.
- 6. Tatu-Chitoiu G, Cinteza M, Dorobantu M, Udeanu M, et al. In-hospital case fatality rates for acute myocardial infarction in Romania. CMAJ. 2009;180(12):1207-13.
- 7. Brezinov O, Klempfner R, Zekry S, Goldenberg I, Kuperstein R. Prognostic value of ejection fraction in patients admitted with acute coronary syndrome. Medicine. 2017;96(9):e6226.
- 8. Dyakova M, Shipkovenska E, Dyakov P, Dimitrov P, Torbova S. Cardiovascular Risk Assessment of Bulgarian Urban Population: Cross-SectionalStudy. CroatMed J. 2008;49(6):783-91.
- 9. Kanazirev B. Survival and prognosis in patients with symptomatic heart failure and disturbed left ventricle systolic and segment function. Science Cardiology. 2011(2):69-73.
- 10. Ren L, Ye H, Wang P, Cui Y, Cao S. Comparison of long-term mortality of acute ST-segment elevation myocardial infarction and non-ST-segment elevation acute coronary syndrome patients after percutaneous coronary intervention. Int J Clin Exp Med. 2014;7(12):5588.
- 11. Jernberg T, Hasvold P, Henriksson M, Hjelm H, Thuresson M, Janzon M. Cardiovascular risk in post-myocardial infarction patients: nationwide real world data demonstrate the importance of a long-term perspective. Eur Heart J. 2015;36(19):1163–70.
- 12. Lee D, Jeong M, Rhee J, Choi J, Lee K, Lee M. And al. Predictors of Long-Term Survival in Acute Coronary Syndrome Patients With Left Ventricular Dysfunction After Percutaneous Coronary Intervention. Korean Circ J. 2012;42(10):692-7.
- 13. Plakht Y, Shiyovich A, Gilutz H. Predictors of long-term (10-year) mortality postmyocardial infarction: Age-related differences. Soroka Acute Myocardial Infarction (SAMI) Project. Cardiology J. 2015;65(3):216-23.
- 14. Santos L, Goulart A, Brandao R, Santos R, Bittencourt M, Sitnik D, & Bensenor I. One-year mortality after an acute coronary event and its clinical predictors: The ERICO Study. Arq Bras Cardio. 2015;105(1):53-64.
- 15. Smolina K, Wright FL, Rayner M, Goldacre MJ. Long-term survival and recurrence after acute myocardial infarction in England, 2004 to 2010. Circ Cardiovasc Qual Outcomes. 2012;5(4):532-40.
- 16. Witt BJ, Brown RD, Jr, Jacobsen SJ, Weston SA, Yawn BP, Roger VL. A community-based study of stroke incidence after myocardial infarction. Ann Intern Med. 2005;143(11):785-92.
- 17. Campo G, Saia F, Guastaroba P, Marchesini J, Varani E, Manari A, Ottani F, Tondi S, De Palma R, Marzocchi A. Prognostic impact of hospital readmissions after primary percutaneous coronary intervention. Arch Intern Med. 2011;171(21):1948-9.
- 18. Ren L, Ye H, Wang P, Cao S. Comparison of long-term mortality of acute ST-segment elevation myocardial infarction and non-ST-segment elevation acute coronary syndrome patients after percutaneous coronary intervention. Int J ClinExp Med. 2014;7(12):5588-92.
- 19. Norgaard ML, Andersen SS, Schramm TK, Folke F, Jorgensen CH, Hansen ML, Andersson C, Bretler DM, Vaag A, Kober L, et al. Changes in short- and long-term cardiovascular risk of incident diabetes and incident myocardial infarction--a nationwide study. Diabetologia. 2010;53(8):1612-9.
- 20. Rapsomaniki E, Thuresson M, Yang E, Blin P, Hunt P, Chung SC, Stogiannis D, Pujades-Rodriguez M, Timmis A, Denaxas SC, et al. Using big data from health records from four countries to evaluate chronic disease outcomes: a study in 114 364 survivors of myocardial infarction. Eur Heart J. 2016;2(3):172-83.
- 21. Rapsomaniki E, Shah A, Perel P, Denaxas S, George J, Nicholas O, Udumyan R, Feder GS, Hingorani AD, Timmis A, et al. Prognostic models for stable coronary artery disease based on electronic health record cohortof 102 023 patients. EurHeart J. 2014;35(13):844-52.
- 22. Fox K, Carruthers K, Dunbar D, Graham C, Manning J, Raedt H, Buysschaert I, Lambrechts D, Van de Werf F. Underestimated and under-recognized: the late consequences of acute coronary syndrome (GRACE UK-Belgian Study). Eur Heart J, 2010;31:2755-64.
- 23. Mauri L, Kereiakes DJ, Yeh RW, Driscoll-Shempp P, Cutlip DE, Steg PG, Normand SL, Braunwald E, Wiviott SD, Cohen DJ, et al. Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents. N Engl J Med. 2014;371(23):2155-66.
- 24. Kiani F, Hesabi N, Arbabisarjou A. Assessment of risk factorsin patients with myocardialinfarction. Glob J Health Sci. 2016;8(1):255-62.
- 25. Anand S, Islam S, Rosengren A, Franzosi M, Steyn K, Yusufali A, Yusuf S. Risk factors for myocardial infarction in women and men: in sights from the INTERHEART study. EHJ. 2008;29(7):932-40.
- 26. 2012 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction (Updating the 2007 Guideline and Replacing the 2011 Focused Update). A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2012;126:875–910.
- 27. Roffi M, Patrono C, Collet J, Mueller C, Valgimigli M, Andreotti F, et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation – Web Addenda Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC) 51. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation – Web Addenda; Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC);2015.EHJ l:3-13.
- 28. Parkhomenko А, Dovgan N, Lutay Y, Kozhukhov S. Markersof poor prognosisinNon-ST segment elevation acute coronary syndromes without revascularization: A 3-year Survival Analysis. JMRI. 2018;2(2):1-6.
- 29. Numasawa Y, Kohsaka S, Miyata H, et al. Gender Differences in In-Hospital Clinical Outcomes after Percutaneous Coronary Interventions: An Insight from a Japanese Multicenter Registry. PLoS One. 2015;10(1):e0116496.
- 30. Vasilevski N, Tsolova G, Dimitrov P, Manolova A. Surveillance of risk factors for noncommunicable diseases among population aged 25-64 within the zones of CINDI programme Bulgaria. Bulgarian Journal of Public Health. 2010;2:3-34.
- 31. Guo Y, Yin F, Fan C, Wang Z. Gender difference in clinical outcomes of the patients with coronary artery disease after percutaneous coronary intervention. A systematic review and meta-analysis. Medicine (Baltimore). 2018;97(30):e11644.
DOI: https://doi.org/10.2478/jbcr-2021-0004 | Journal eISSN: 1313-9053
Language: English
Page range: 31 - 46
Submitted on: Aug 20, 2020
Accepted on: May 27, 2021
Published online: Jul 12, 2021
Published in print: Jun 1, 2021
Published by: Sciendo
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Keywords:
Related subjects:
© 2021 Krastina I. Doneva-Basheva, Damyan P. Petrov, Tatyana I. Vlaykova, Snezhana T. Tisheva, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.